XAGEW — Longevity Health Holdings, Inc.

OTC · Materials · Chemicals · CIK 1842939 ·
Last close
Market Cap
52W High
52W Low
ADV30
Next earnings
Longevity Health Holdings, Inc., a bio-aesthetics company, focuses on developing, manufacturing, and marketing cosmetic skincare and haircare products. The company utilizes Carmell Secretome and Elevai Exosomes to support skin and hair health. Its Carmell Secretome consists of growth factors, proteins, and peptides extracted from allogeneic human platelets; and Elevai Exosomes constains growth factors, cytokines, peptides, and other small molecules involved in the body's natural healing process. The company also develops a microemulsion formulation that enables delivery of lipophilic and hydrophilic ingredients without relying on the Foul Fourteen, 14 potentially harmful excipients that are commonly used by other companies to impart texture, stability, and other desirable physicochemical attributes to cosmetic products. It has licensing agreement with Carnegie Mellon University to develop and commercialize biocompatible plasma-based plastics. The company was formerly known as Carmell Corporation and changed its name to Longevity Health Holdings, Inc. in March 2025. Longevity Health Holdings, Inc. was founded in 2008 and is headquartered in Pittsburgh, Pennsylvania.

Quarterly Fundamentals

Revenues vs Net Income (last 4 Q)

Assets vs Liabilities (last 4 Q)

PeriodRevenuesGrossProfit OpIncomeNetIncomeAssets CashLiabilities
Mar 2026 391,764 237,025 -1,328,492 -1,431,713 1,642,393 313,396 8,537,309
Dec 2025 472,982 267,816 -2,271,201 -2,083,222 2,367,027 706,740 8,233,900
Sep 2025 425,864 254,463 -1,471,017 -1,429,755 3,298,979 1,109,228 7,276,342
Jun 2025 503,612 302,658 -1,858,604 -1,886,438 3,719,342 1,551,199 7,456,876

Cashflow TTM (yfinance, fills SEC gap)

Operating CF
$-3,329,266
Investing CF
$-164,225
Financing CF
$4,043,092
CapEx
$-1
Dividends Paid
Buybacks
EPS Diluted TTM
As of
2026-05-10

Balance + Analyst (yfinance extras)

Retained Earnings
$-75,776,944
Inventory
$963,028
Receivables
$36,500
ST Investments
EBIT TTM
$-6,850,806
Pretax Income TTM
$-6,869,020
Interest Exp TTM
$18,214
Analysts

Yahoo Snapshot (yfinance, live)

Total Revenue
$1,794,222
EBITDA
$-6,707,055
Free Cash Flow
$-513,088
Enterprise Value
Total Cash
$313,396
Total Debt
$400,615
Shares Out
Trailing EPS
Book Value
$-2.23
ROE
ROA
-170.1%
Div Yield

Annual Trend (SEC EDGAR, last 5y)

Revenues vs Net Income (last 5y)

FY endRevenuesOpIncome NetIncomeAssetsLiabilities EquityOCF
Dec 2025 1,912,811 -7,107,573 -6,905,282 2,367,027 8,233,900 -3,329,266
Dec 2024 50,318 -4,998,498 -10,368,261 1,473,980 6,186,642 -3,893,256
Dec 2023 0 -5,217,276 -15,445,087 63,948,803 39,199,793 -8,348,208
Dec 2022 0 -5,507,641 -9,051,334 1,748,547 39,539,086 -3,428,707
Dec 2021

Peers — same industry

TickerNameMarket CapLastDaily %
PG PROCTER & GAMBLE Co $332.90B $142.96
LIN LINDE PLC $238.09B $514.97
UL UNILEVER PLC $123.97B $57.07
CL COLGATE PALMOLIVE CO $71.90B $89.85
ECL ECOLAB INC. $71.55B $254.23

News headlines (Yahoo Finance, 1h cache)

Longevity Health and Innovaccer Announce Enterprise AI Center of Excellence After Achieving $1M Cost Savings
2026-03-26 13:00 · Yahoo
Longevity Health Holdings Closes Strategic Investment and Appoints Ram Ajjarapu as Chairman and CEO to Drive Acquisition-Focused Growth
2026-03-17 12:30 · Yahoo
Longevity Health Achieves Top Ratings in CMS Star Quality Measures: A Testament to Excellence in Member Care
2025-10-15 15:30 · Yahoo
Top Midday Gainers
2025-07-15 17:40 · Yahoo
Longevity Health Holdings Announces Merger with THPlasma and Termination of 20/20 BioLabs Transaction
2025-07-14 20:30 · Yahoo
Longevity Health extends cash runway into 1Q26
2025-05-28 13:25 · Yahoo
Longevity Health Holdings, Inc. Announces Successful Fundraising Via ATM Sale
2025-05-27 13:20 · Yahoo

Recent Insider Activity

No insider activity indexed for this ticker.